Ryman Healthcare Limited
RHCGFOTCHealthcare● Active
$1.41
+$0.00(+0.00%)
Market Cap$1.4B
P/E Ratio—
52W High$3.11
52W Low$1.21
Ryman Healthcare Limited (RHCGF) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · RHCGF · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2026-03 | 2025-03 | 2024-03 | 2023-03 | 2022-03 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.81B | $0.71B | $0.65B | $0.56B | $0.50B |
| Cost of Revenue | $0.82B | $0.00B | $0.65B | $0.58B | $0.50B |
| Gross Profit | ($0.02B) | $0.71B | ($0.00B) | ($0.02B) | $0.00B |
| Gross Margin %(computed) | -2.22% | 100.00% | -0.21% | -3.53% | 0.36% |
| Operating Expenses | |||||
| R&D Expenses | $0.00B | $0.00B | $0.02B | $0.01B | $0.01B |
| G&A Expenses | $0.00B | $0.51B | $0.41B | $0.18B | $0.31B |
| Total Operating Expenses | $0.00B | $0.83B | $0.72B | $0.22B | $0.71B |
| Operating Income | ($0.02B) | ($0.12B) | ($0.07B) | ($0.02B) | $0.00B |
| Operating Margin %(computed) | -2.22% | -16.57% | -10.70% | -3.53% | 0.36% |
| Interest Income | $0.04B | $0.00B | $0.00B | $0.00B | $0.00B |
| Interest Expense | $0.12B | $0.14B | $0.05B | $0.12B | $0.03B |
| Income Before Tax | ($0.18B) | ($0.22B) | ($0.14B) | $0.21B | $0.72B |
| Income Tax Expense | ($0.01B) | $0.22B | ($0.15B) | ($0.05B) | $0.03B |
| Net Income | ($0.17B) | ($0.44B) | $0.00B | $0.26B | $0.69B |
| Net Margin %(computed) | -21.46% | -61.20% | 0.73% | 46.03% | 137.54% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-0.17 | $-0.61 | $0.01 | $0.50 | $1.31 |
| Wtd Avg Shares | 1.02B | 0.71B | 0.69B | 0.52B | 0.53B |
| EBITDA | $0.03B | ($0.03B) | ($0.05B) | $0.46B | $0.79B |
| EBITDA Margin %(computed) | 3.10% | -3.80% | -7.80% | 81.77% | 156.47% |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · NZD · B
Explore more Ryman Healthcare Limited data
About Ryman Healthcare Limited (RHCGF) Income Statement
Ryman Healthcare Limited (RHCGF) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2026, RHCGF reported revenue of $0.81B, gross profit of ($0.02B) (gross margin -2.22%), and net income of ($0.17B) — a net profit margin of -21.46%.
Frequently asked questions
RHCGF · 4 questionsRyman Healthcare Limited (RHCGF) reported revenue of $0.81B for 2026, up 13.0% year-over-year.
RHCGF revenueRHCGF salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08